Includes Suvorexant in the Schedule IV list of depressant drugs

This bill adds the sleep medication Suvorexant to Schedule IV of New York's public health law, which regulates depressant drugs with lower abuse potential but still requiring medical oversight. It directly affects healthcare providers who prescribe Suvorexant and patients using this medication, as it will subject it to specific state regulations for prescribing and dispensing. The key provision amends Schedule IV by inserting "Suvorexant" as a new entry under controlled substances. The bill takes effect 90 days after enactment, pending legislative approval. (Note: The bill is procedural, as it modifies drug scheduling rather than creating new policy.)